Therapy Cells Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2008
2009
2012
2013
2014
Sales/Revenue
1,385.60
-
10.20
-
-
Cost of Goods Sold (COGS) incl. D&A
848.00
-
-
0.40
1.10
Gross Income
537.60
-
-
0.40
1.10
SG&A Expense
1,631.30
-
130.10
94.40
29.30
EBIT
1,093.60
-
119.90
94.90
30.40
Non Operating Income/Expense
1.40
-
-
-
-
Interest Expense
103.70
-
5.60
1.40
26.20
Pretax Income
1,196.00
-
125.50
96.30
56.60
Consolidated Net Income
1,106.90
-
125.50
96.30
56.60
Net Income
1,106.90
-
125.50
96.30
56.60
Net Income After Extraordinaries
1,106.90
173.00
125.50
96.30
56.60
Net Income Available to Common
1,106.90
173.00
125.50
96.30
56.60
EPS (Basic)
-
-
0.00
0.00
0.00
Basic Shares Outstanding
0.00
0.00
77,297.40
110,547.40
650,067.20
EPS (Diluted)
127,459.09
20,944.88
0.00
0.00
0.00
Diluted Shares Outstanding
0.00
0.00
77,297.40
110,547.40
650,067.20
EBITDA
1,031.90
-
119.90
94.40
29.30
About Therapy Cells
View Profile
